Extractables and Leachables (E&L) Testing

Introduction Achieving Extractables and Leachables (E&L) Compliance for a Dry Powder Inhaler intended for European Medicines Agency (EMA) approval demands […]

Introduction: Extractables and Leachables Testing for Prefilled Syringes has become an essential requirement for pharmaceutical companies developing injectable biologics, biosimilars,

Introduction Method Validation for Leachables Testing in a Good Manufacturing Practice (GMP) laboratory provides documented, objective evidence that an analytical

Introduction Producing audit-ready Extractables and Leachables (E&L) data depends on a scientifically defensible, cGMP-compliant testing architecture capable of proving that

Introduction Container closure elastomers are considered one of the most significant sources of extractables and leachables in pharmaceutical packaging. Their

Introduction: GMP Data Integrity for Extractables and Leachables Testing has become one of the most important compliance requirements in pharmaceutical

Introduction: E&L testing vs drug device compatibility studies comes down to one core distinction: E&L testing asks what chemicals migrate

Introduction Establishing a validated GMP Extractables and Leachables Testing program is an essential aspect of modern pharmaceutical development. It ensures

Introduction: Nitrosamine leachables in blister packaging have become one of the most closely scrutinized contamination pathways in oral solid dosage

Introduction Extractables & Leachables (E&L) Testing for Biosimilar Drug Development is a highly specialized, risk-based analytical approach developed to detect,